Search Results - "Brennan, Michael D."

Refine Results
  1. 1

    Professionalism: Good for Patients and Health Care Organizations by Brennan, Michael D., MD, FRCPI, Monson, Verna, PhD

    Published in Mayo Clinic proceedings (01-05-2014)
    “…Abstract Professionalism is an indispensable element in the compact between the medical profession and society that is based on trust and putting the needs of…”
    Get full text
    Journal Article
  2. 2

    Endocrinopathy in POEMS Syndrome: The Mayo Clinic Experience by Gandhi, Gunjan Y., MD, MSc, Basu, Rita, MD, Dispenzieri, Angela, MD, Basu, Ananda, MD, Montori, Victor M., MD, MSc, Brennan, Michael D., MD

    Published in Mayo Clinic proceedings (01-07-2007)
    “…OBJECTIVE To determine the prevalence and characteristics of endocrinopathies at diagnosis of POEMS ( p olyneuropathy, o rganomegaly, e ndocrinopathy, M…”
    Get full text
    Journal Article
  3. 3

    Surgical Management of Amiodarone‐associated Thyrotoxicosis: Mayo Clinic Experience by Houghton, Scott G., Farley, David R., Brennan, Michael D., van Heerden, Jon A., Thompson, Geoffrey B., Grant, Clive S.

    Published in World journal of surgery (01-11-2004)
    “…Amiodarone‐associated thyrotoxicosis (AAT) is often poorly tolerated owing to underlying cardiac disease, and it is frequently refractory to conventional…”
    Get full text
    Journal Article
  4. 4

    A Risk Prediction Index for Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease by Montori, Victor M., Brennan, Michael D., Ammash, Naser M., Thapa, Prabin, Warnes, Carole A., Bahn, Rebecca S., Stan, Marius N., Hess, Erik P.

    Published in Journal of Thyroid Research (01-01-2012)
    “…Amiodarone therapy in adults with congenital heart disease (CHD) is associated with a significant risk of amiodarone-induced thyrotoxicosis (AIT). We developed…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease—A cohort study by Stan, Marius N, Ammash, Naser M, Warnes, Carole A, Brennan, Michael D, Thapa, Prabin, Nannenga, Michael R, Bahn, Rebecca S

    Published in International journal of cardiology (10-08-2013)
    “…Abstract Introduction Amiodarone-induced thyrotoxicosis (AIT) is a recognized complication of amiodarone treatment with limited management options. Its…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The impact of overt and subclinical hyperthyroidism on skeletal muscle by Brennan, Michael D, Powell, Claudia, Kaufman, Kenton R, Sun, Pi Chang, Bahn, Rebecca S, Nair, K Sreekumaran

    Published in Thyroid (New York, N.Y.) (01-04-2006)
    “…Patients with overt hyperthyroidism (OH) commonly have proximal limb muscle weakness that improves after correction of hyperthyroidism. It is unclear, however,…”
    Get more information
    Journal Article
  9. 9

    Changes in body composition in women following treatment of overt and subclinical hyperthyroidism by Greenlund, Laura J S, Nair, K Sreekumaran, Brennan, Michael D

    Published in Endocrine practice (01-11-2008)
    “…To determine changes in weight, body composition, and bone density after treatment of overt hyperthyroidism (OH) and subclinical hyperthyroidism (SCH) in…”
    Get more information
    Journal Article
  10. 10

    Amiodarone-induced thyrotoxicosis in adults with congenital heart disease--clinical presentation and response to therapy by Stan, Marius N, Sathananthan, Matheni, Warnes, Carole A, Brennan, Michael D, Thapa, Prabin, Bahn, Rebecca S

    Published in Endocrine practice (01-01-2014)
    “…The development of amiodarone-induced thyrotoxicosis (AIT) can threaten the hemodynamic stability of adult patients with congenital heart disease (CHD). Here,…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Development and application of magnetic resonance elastography of the normal and pathological thyroid gland in vivo by Bahn, Mark M., Brennan, Michael D., Bahn, Rebecca S., Dean, Diana S., Kugel, Jennifer L., Ehman, Richard L.

    Published in Journal of magnetic resonance imaging (01-11-2009)
    “…Purpose: To noninvasively assess the shear stiffness of the thyroid gland in vivo in order to determine whether magnetic resonance elastography (MRE) might…”
    Get full text
    Journal Article
  13. 13

    Changes in Skeletal Muscle Protein Metabolism and Myosin Heavy Chain Isoform Messenger Ribonucleic Acid Abundance after Treatment of Hyperthyroidism by Brennan, Michael D., Coenen-Schimke, Jill M., Bigelow, Maureen L., Nair, K. Sreekumaran

    “…Background: Hyperthyroidism causes a hypermetabolic state and skeletal muscle dysfunction, but the underlying mechanism remains incompletely defined…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The effect of computerized physician-order entry on outpatient prescription errors by Varkey, Prathibha, Aponte, Philip, Swanton, Claudia, Fischer, Deborah, Johnson, Susan F, Brennan, Michael D

    Published in Managed care interface (01-03-2007)
    “…Little information is available regarding the use of computerized physician-order entry (CPOE) in the outpatient setting or the role of pharmacists in…”
    Get more information
    Journal Article
  16. 16
  17. 17

    The Application of Design Principles to Innovate Clinical Care Delivery by Brennan, Michael D., Duncan, Alan K., Armbruster, Ryan R., Montori, Victor M., Feyereisn, Wayne L., LaRusso, Nicholas F.

    Published in Journal for healthcare quality (01-01-2009)
    “…: Clinical research centers that support hypothesis‐driven investigation have long been a feature of academic medical centers but facilities in which clinical…”
    Get full text
    Journal Article
  18. 18

    Symptomatic hyperthyroidism in a patient taking the dietary supplement tiratricol by Bauer, Brent A, Elkin, Peter L, Erickson, Dana, Klee, George G, Brennan, Michael D

    Published in Mayo Clinic proceedings (01-06-2002)
    “…An 87-year-old woman was referred for evaluation of nervousness, tremor, insomnia, and fatigue of 2 months' duration. Initial laboratory evaluation revealed a…”
    Get more information
    Journal Article
  19. 19

    Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome by Brennan, M D, Bergstralh, E J, van Heerden, J A, McConahey, W M

    Published in Mayo Clinic proceedings (01-01-1991)
    “…We retrospectively analyzed the outcome of all patients who received their primary treatment for follicular thyroid cancer at the Mayo Clinic between 1946 and…”
    Get more information
    Journal Article
  20. 20

    Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo by Brennan, M D, Erickson, D Z, Carney, J A, Bahn, R S

    Published in Thyroid (New York, N.Y.) (01-06-1995)
    “…Treatment with the antiarrhythmic agent amiodarone results in alterations in thyroid hormone metabolism, and can induce either hypothyroidism or…”
    Get more information
    Journal Article